Production currently suspended due to Covid-19.

Emergent Biosolutions

Save up to 12% on Emergent Biosolutions’ vaccines

Create an account to learn more about membership benefits and pricing.
Sign Up
  • Clipboard-check icon

    Save up to 12% on Vivotif® Oral Typhoid vaccine

    Enjoy the lowest prices on all of Emergent's vaccines.

  • Clipboard-check icon

    Save up to 6.5% for Vaxchora® vaccine

    Enjoy the lowest prices on all of Emergent's vaccines.

  • Clipboard-check icon

    Conveniently purchase directly from

    Create a Emergent Biosolutions account and select PBG via PracticeWell as the GPO.

  • Clipboard-check icon

    Rebates earned on all Vivotif® and Vaxchora® purchases

    These generous rebates lower your overall cost.

  • Clipboard-check icon

    No minimum purchase necessary for contract discount

  • Clipboard-check icon

    Free shipping

About Emergent BioSolutions

Previously, Emergent BioSolutions focused on developing, manufacturing, and commercializing specialty vaccines that protect against existing and emerging infectious diseases. In 2018, Emergent BioSolutions was acquired by Emergent Solutions. Through the acquisition, Vivotif®, the only oral vaccine licensed by the U.S. Food and Drug Administration (FDA) for the prevention of typhoid fever (Typhoid Vaccine Live Oral Ty21a) and Vaxchora® Cholera Vaccine (Live, Oral), were acquired.

What is Vivotif®?

Vivotif® is a vaccine for typhoid fever. Taken orally, the vaccine is delivered to the mucosal surface of the gastrointestinal tract—the largest immunologic organ in the body. The vaccine provides sustained efficacy for 5 years.

Vivotif logo

What is Vaxchora®?

Vaxchora ® is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas.

Vaxchora logo

Join PBG Today

Get access to these benefits by joining PBG

Start Now

We make it easy to do more for your patients and practice.